Levitsky Hyam

EVP, Research & CSO at Juno Therapeutics, Inc.

Sold, on record
$531k
Dollars the filings state
Form 4 sales
1
Latest Jun 17, 2016
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale Juno Therapeutics, Inc.Plan not stated
    Jun 17, 2016 2016

    Sold 12,418 shares at $42.77 ($531k)

    Levitsky Hyam, EVP, Research & CSO

    Sold 9.6% of holdings ($5.5M position)116,700 shares leftFirst sale on recordFiling

Every transaction

Loading transactions…

Sales and notices (1)

Form 144 notices and Form 4 sales by Levitsky Hyam
Source
Jun 17, 2016Jun 21, 2016Juno Therapeutics, Inc.EVP, Research & CSOForm 4 sale12,418$531k9.6%Plan not statedSEC